Skip to main content
logo
Dongbang Medical Co., Ltd (KOSDAQ:240550)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,580.00
-90.00 (-1.59%)
Sep 11, 2026, 3:30 PM KST

Dongbang Medical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
125,117113,537105,11490,87581,408
Revenue Growth
15.52%8.01%15.67%11.63%-
Gross Profit
45,57740,14334,09430,74122,520
Operating Income
21,20016,25215,47617,1825,560
Net Income
16,11911,7032,9149,7753,192
Earnings Per Share
765.27564.00180.07617.82215.05
EPS Growth
50.10%213.20%-70.85%187.29%-

Revenue by Segment
Chart
Fiscal YearFY 2024
Period EndingDec '24
Beauty and Other Business
64,285
Oriental Medicine Business
40,828
Total
105,114

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
32,05833,52816,94516,49118,963
Total Debt
38,69533,20443,42631,94334,428
Net Cash (Debt)
-6,637323.94-26,481-15,452-15,465
Net Cash Growth
-----
Net Cash Per Share
-315.2115.60-1636.29-883.13-1042.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
16,21512,02418,5486,27610,474
Capital Expenditures
-22,450-14,528-13,140-4,465-6,095
Free Cash Flow
-6,235-2,5055,4081,8114,379
Free Cash Flow Growth
--198.58%-58.64%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
36.43%35.36%32.44%33.83%27.66%
Operating Margin
16.94%14.31%14.72%18.91%6.83%
Pretax Margin
15.97%12.58%6.46%13.76%6.90%
Profit Margin
12.88%10.31%2.77%10.76%3.92%
FCF Margin
-4.98%-2.21%5.15%1.99%5.38%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
7.2913.89---
Forward PE
-7.99---
PS Ratio
0.931.43---